J Pediatr Neurol
DOI: 10.1055/s-0039-1683436
Case Report
Georg Thieme Verlag KG Stuttgart · New York

An Unusual Case of Infantile Spasms Due to a Pathogenic Variant in the MECP2 Gene

Behshad Charkhand
1  Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
2  Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada
,
Natarie Liu
3  Department of Clinical Neurosciences, Cumming School of Medicine University of Calgary, Calgary, Alberta, Canada
,
Karlene T. Barrett
1  Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
2  Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada
,
Walla Al-Hertani
1  Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
4  Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
,
Morris H. Scantlebury
1  Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
2  Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada
3  Department of Clinical Neurosciences, Cumming School of Medicine University of Calgary, Calgary, Alberta, Canada
› Institutsangaben
Funding None.
Weitere Informationen

Publikationsverlauf

26. November 2018

08. Februar 2019

Publikationsdatum:
13. März 2019 (online)

Abstract

The infantile spasms (IS) syndrome is a developmental epileptic encephalopathy disorder characterized by epileptic spasms occurring in infancy, hypsarrhythmia on the electroencephalography (EEG) and developmental arrest or regression. The etiologies include structural, metabolic, and genetic causes. We report an unusual case of IS due to a de novo variant in the MECP2 gene. The patient also had variants of uncertain significance in the SCN9A and SCN5A genes inherited from the father and mother, respectively. This report highlights the need for broad genetic testing in MECP2-related disorders with atypical presentations to better understand the disease etiology.